Dataset Information

Exposure to polymers reverses inhibition of pulmonary surfactant by serum, meconium, or cholesterol in the captive bubble surfactometer.

ABSTRACT: Dysfunction of pulmonary surfactant in the lungs is associated with respiratory pathologies such as acute respiratory distress syndrome or meconium aspiration syndrome. Serum, cholesterol, and meconium have been described as inhibitory agents of surfactant's interfacial activity once these substances appear in alveolar spaces during lung injury and inflammation. The deleterious action of these agents has been only partly evaluated under physiologically relevant conditions. We have optimized a protocol to assess surfactant inhibition by serum, cholesterol, or meconium in the captive bubble surfactometer. Specific measures of surface activity before and after native surfactant was exposed to inhibitors included i), film formation, ii), readsorption of material from surface-associated reservoirs, and iii), interfacial film dynamics during compression-expansion cycling. Results show that serum creates a steric barrier that impedes surfactant reaching the interface. A mechanical perturbation of this barrier allows native surfactant to compete efficiently with serum to form a highly surface-active film. Exposure of native surfactant to cholesterol or meconium, on the other hand, modifies the compressibility of surfactant films though optimal compressibility properties recover on repetitive compression-expansion cycling. Addition of polymers like dextran or hyaluronic acid to surfactant fully reverses inhibition by serum. These polymers also prevent surfactant inhibition by cholesterol or meconium, suggesting that the protective action of polymers goes beyond the mere enhancement of interfacial adsorption as described by depletion force theories.

SUBMITTER: Lopez-Rodriguez E

PROVIDER: S-EPMC3471484 | biostudies-literature | 2012 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Exposure to polymers reverses inhibition of pulmonary surfactant by serum, meconium, or cholesterol in the captive bubble surfactometer.

López-Rodríguez Elena E Ospina Olga Lucía OL Echaide Mercedes M Taeusch H William HW Pérez-Gil Jesús J

Biophysical journal 20121002 7

Dysfunction of pulmonary surfactant in the lungs is associated with respiratory pathologies such as acute respiratory distress syndrome or meconium aspiration syndrome. Serum, cholesterol, and meconium have been described as inhibitory agents of surfactant's interfacial activity once these substances appear in alveolar spaces during lung injury and inflammation. The deleterious action of these agents has been only partly evaluated under physiologically relevant conditions. We have optimized a pr ...[more]

PMID: 23062337

Similar Datasets

Project description:Robots operating in changing underwater environments may be required to adapt to these varying conditions. In tidal estuaries, for example, where the degree of salinity cycles in step with the level of the water, a robot may need to adapt its behaviour depending on the position of the tide. In freshwater bodies, the unexpected presence of a pollutant may also require the robot to respond by altering its behaviour. Embodying this sensing and response in the body of the robot means that adaptivity to the environment can be achieved without resorting to centralised control. This can also allow direct responsivity using 'free' environmental energy, actuating without requiring stored onboard energy. In this work we present a soft artificial muscle, the contraction of which varies in response to the salinity the water surrounding it. The novel actuator uses a super-absorbent polymer gel encapsulated within a series of discrete cells. This gel readily absorbs water through the membrane wall of the actuator, and can swell to over 300 times its initial volume. This swelling generates significant pressure, changing the shape of the cells and driving the contraction of the muscle. The degree of swelling is significantly reduced by the presence of salts and pollutants in the surrounding water, so transitioning from a freshwater to a saltwater environment causes the muscle to relax. In this paper, we discuss the design and fabrication of these superabsorbent polymer-based Bubble Artificial Muscle (SAP-BAM) actuators. The tensile properties of the muscle under actuated (fresh water) and relaxed (salt water) conditions are characterised, showing a maximum generated force of 10.96N. The length response under constant load for a full actuation cycle is given, showing a maximum contraction of 27.5% of the initial length at 1N load, and the performance over repeated actuation and relaxation cycles is shown. The SAP-BAM muscles are straightforward to fabricate and are composed of low-cost, freely-available materials. Many existing pneumatically-actuated muscles can be modified to use the approach taken for this muscle. The muscle presented in this work represents the first example of a new class of super-absorbent polymer-driven environmental soft artificial muscles.

Project description:The presence of cholesterol is critical in defining a dynamic lateral structure in pulmonary surfactant membranes. However, an excess of cholesterol has been associated with impaired surface activity of surfactant. It has also been reported that surfactant protein SP-C interacts with cholesterol in lipid/protein interfacial films. In this study, we analyzed the effect of SP-C on the thermodynamic properties of phospholipid membranes containing cholesterol, and the ability of lipid/protein complexes containing cholesterol to form and respread interfacial films capable of producing very low surface tensions upon repetitive compression-expansion cycling. SP-C modulates the effect of cholesterol to reduce the enthalpy associated with the gel-to-liquid-crystalline melting transition in dipalmitoylphosphatidylcholine (DPPC) bilayers, as analyzed by differential scanning calorimetry. The presence of SP-C affects more subtly the effects of cholesterol on the thermotropic properties of ternary membranes, mimicking more closely the lipid composition of native surfactant, where SP-C facilitates the miscibility of the sterol. Incorporation of 1% or 2% SP-C (protein/phospholipid by weight) promotes almost instantaneous adsorption of suspensions of DPPC/palmitoyloleoylphospatidylcholine (POPC)/palmitoyloleoyl-phosphatidylglycerol (POPG) (50:25:15, w/w/w) into the air-liquid interface of a captive bubble, in both the absence and presence of cholesterol. However, cholesterol impairs the ability of SP-C-containing films to achieve very low surface tensions in bubbles subjected to compression-expansion cycling. Cholesterol also substantially impairs the ability of DPPC/POPC/POPG films containing 1% surfactant protein SP-B to mimic the interfacial behavior of native surfactant films, which are characterized by very low minimum surface tensions with only limited area change during compression and practically no compression-expansion hysteresis. However, the simultaneous presence of 2% SP-C practically restores the compression-expansion dynamics of cholesterol- and SP-B-containing films to the efficient behavior shown in the absence of cholesterol. This suggests that cooperation between the two proteins is required for lipid-protein films containing cholesterol to achieve optimal performance under physiologically relevant compression-expansion dynamics.

Dataset Information

Exposure to polymers reverses inhibition of pulmonary surfactant by serum, meconium, or cholesterol in the captive bubble surfactometer.

Publications

Exposure to polymers reverses inhibition of pulmonary surfactant by serum, meconium, or cholesterol in the captive bubble surfactometer.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets